NO995938D0 - Mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione - Google Patents

Mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione

Info

Publication number: NO995938D0
Authority: NO; Norway
Prior art keywords: thiazolidine; dione; pyridyl; ethoxy; benzyl
Prior art date: 1997-06-05

Application number

NO995938A

Other languages

Norwegian (no)

Other versions

NO995938L (en

Inventor

Jai Patel

Hamish Ross

Jeffrey Roger Granett

Robin Price

Paul Nigel Wray

Original Assignee

Smithkline Beecham Plc

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-05

Filing date

1999-12-03

Publication date

1999-12-03

1997-06-18 Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en

1999-12-03 Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc

1999-12-03 Publication of NO995938D0 publication Critical patent/NO995938D0/en

2000-02-02 Publication of NO995938L publication Critical patent/NO995938L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

NO995938A 1997-06-05 1999-12-03 Mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione NO995938L (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9711683.4A GB9711683D0 (en)	1997-06-05	1997-06-05	Composition
GBGB9712851.6A GB9712851D0 (en)	1997-06-18	1997-06-18	Composition
PCT/EP1998/003478 WO1998055122A1 (en)	1997-06-05	1998-06-02	Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Publications (2)

Publication Number	Publication Date
NO995938D0 true NO995938D0 (en)	1999-12-03
NO995938L NO995938L (en)	2000-02-02

Family

ID=26311662

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO995938A NO995938L (en)	1997-06-05	1999-12-03	Mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
NO20040738A NO20040738L (en)	1997-06-05	2004-02-20	A mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl]) -amino) ethoxyl] benzyl] thiazolidine-2,4-dione.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20040738A NO20040738L (en)	1997-06-05	2004-02-20	A mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl]) -amino) ethoxyl] benzyl] thiazolidine-2,4-dione.

Country Status (29)

Country	Link
EP (1)	EP0998284A1 (en)
JP (1)	JP2001521553A (en)
KR (1)	KR20010013410A (en)
CN (3)	CN1112926C (en)
AP (1)	AP1214A (en)
AR (2)	AR015120A1 (en)
AU (1)	AU8215098A (en)
BG (1)	BG104048A (en)
BR (1)	BR9810405A (en)
CA (2)	CA2292629C (en)
CO (1)	CO4940400A1 (en)
DZ (1)	DZ2510A1 (en)
EA (1)	EA002384B1 (en)
GB (1)	GB9711683D0 (en)
HU (1)	HUP0004070A3 (en)
ID (1)	ID24264A (en)
IL (1)	IL133074A0 (en)
MX (1)	MXPA99011322A (en)
NO (2)	NO995938L (en)
NZ (2)	NZ523725A (en)
OA (1)	OA11306A (en)
PE (1)	PE78899A1 (en)
PL (1)	PL337201A1 (en)
SK (1)	SK164899A3 (en)
TR (2)	TR199902963T2 (en)
TW (1)	TW570797B (en)
UY (1)	UY25032A1 (en)
WO (1)	WO1998055122A1 (en)
ZA (2)	ZA984826B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
CN1167702C (en) *	1999-04-23	2004-09-22	史密丝克莱恩比彻姆有限公司	Polymroph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt
MXPA01010820A (en)	1999-04-23	2002-06-04	Smithkline Beecham Plc	Novel pharmaceutical.
GB0021978D0 (en)	2000-09-07	2000-10-25	Smithkline Beecham Plc	Novel pharmaceutical
GB0127805D0 (en) *	2001-11-20	2002-01-09	Smithkline Beecham Plc	Pharmaceutical composition
WO2003050112A1 (en) *	2001-12-13	2003-06-19	Smithkline Beecham Plc	Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0129871D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0130509D0 (en) *	2001-12-20	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
EP2270007A1 (en) *	2006-05-09	2011-01-05	Teva Pharmaceutical Industries Ltd.	2-N-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2-4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
US7435741B2 (en)	2006-05-09	2008-10-14	Teva Pharmaceutical Industries, Ltd.	2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (en) *	2013-07-17	2015-01-22	Glenmark Pharmaceuticals S.A.	Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE186724T1 (en) *	1987-09-04	1999-12-15	Beecham Group Plc	SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVES
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
WO1995021608A1 (en) *	1994-02-10	1995-08-17	Smithkline Beecham Plc	Use of insulin sensitisers for treating renal diseases
KR19990036290A (en) *	1995-08-10	1999-05-25	로즈 암스트롱	Reduction of Exogenous Insulin Dosage in Non-insulin-Dependent Diabetic Patients
AU7604596A (en) *	1995-11-17	1997-06-11	Warner-Lambert Company	A method of treating myotonic dystrophy
NZ314406A (en) *	1996-03-18	2000-12-22	Sankyo Co	Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
JP2000514807A (en) *	1996-07-12	2000-11-07	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	Novel treatment for leptin resistance

1997
- 1997-06-05 GB GBGB9711683.4A patent/GB9711683D0/en active Pending
1998
- 1998-06-02 AU AU82150/98A patent/AU8215098A/en not_active Abandoned
- 1998-06-02 TR TR1999/02963T patent/TR199902963T2/en unknown
- 1998-06-02 HU HU0004070A patent/HUP0004070A3/en unknown
- 1998-06-02 CA CA002292629A patent/CA2292629C/en not_active Expired - Fee Related
- 1998-06-02 KR KR19997011411A patent/KR20010013410A/en not_active Application Discontinuation
- 1998-06-02 EA EA199901116A patent/EA002384B1/en not_active IP Right Cessation
- 1998-06-02 IL IL13307498A patent/IL133074A0/en unknown
- 1998-06-02 PL PL98337201A patent/PL337201A1/en unknown
- 1998-06-02 WO PCT/EP1998/003478 patent/WO1998055122A1/en not_active Application Discontinuation
- 1998-06-02 MX MXPA99011322A patent/MXPA99011322A/en unknown
- 1998-06-02 CA CA002333352A patent/CA2333352A1/en not_active Abandoned
- 1998-06-02 AP APAP/P/1999/001696A patent/AP1214A/en active
- 1998-06-02 TR TR2000/02790T patent/TR200002790T2/en unknown
- 1998-06-02 ID IDW991520A patent/ID24264A/en unknown
- 1998-06-02 CN CN98805686A patent/CN1112926C/en not_active Expired - Lifetime
- 1998-06-02 JP JP50158799A patent/JP2001521553A/en not_active Ceased
- 1998-06-02 SK SK1648-99A patent/SK164899A3/en unknown
- 1998-06-02 BR BR9810405-5A patent/BR9810405A/en not_active IP Right Cessation
- 1998-06-02 EP EP98932144A patent/EP0998284A1/en not_active Withdrawn
- 1998-06-02 NZ NZ523725A patent/NZ523725A/en unknown
- 1998-06-02 CN CNA2003101199090A patent/CN1526391A/en active Pending
- 1998-06-03 DZ DZ980120A patent/DZ2510A1/en active
- 1998-06-04 AR ARP980102650A patent/AR015120A1/en not_active Application Discontinuation
- 1998-06-04 ZA ZA9804826A patent/ZA984826B/en unknown
- 1998-06-04 UY UY25032A patent/UY25032A1/en not_active IP Right Cessation
- 1998-06-04 ZA ZA9811572A patent/ZA9811572B/en unknown
- 1998-06-04 CO CO98031614A patent/CO4940400A1/en unknown
- 1998-06-04 AR ARP980102649A patent/AR008198A1/en not_active Application Discontinuation
- 1998-06-05 PE PE1998000466A patent/PE78899A1/en not_active Application Discontinuation
- 1998-10-23 TW TW087117536A patent/TW570797B/en not_active IP Right Cessation
1999
- 1999-12-02 OA OA9900267A patent/OA11306A/en unknown
- 1999-12-03 NO NO995938A patent/NO995938L/en not_active Application Discontinuation
- 1999-12-27 BG BG104048A patent/BG104048A/en unknown
2001
- 2001-09-03 NZ NZ513922A patent/NZ513922A/en unknown
2002
- 2002-11-05 CN CN02149972A patent/CN1430959A/en active Pending
2004
- 2004-02-20 NO NO20040738A patent/NO20040738L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP0998284A1 (en)	2000-05-10
NO995938L (en)	2000-02-02
BR9810405A (en)	2000-08-29
CO4940400A1 (en)	2000-07-24
EA199901116A1 (en)	2000-06-26
OA11306A (en)	2003-10-22
TR199902963T2 (en)	2000-02-21
TW570797B (en)	2004-01-11
NZ523725A (en)	2004-09-24
WO1998055122A1 (en)	1998-12-10
PL337201A1 (en)	2000-08-14
AU8215098A (en)	1998-12-21
PE78899A1 (en)	1999-10-22
CA2292629C (en)	2004-01-06
BG104048A (en)	2000-07-31
AP1214A (en)	2003-10-08
HUP0004070A3 (en)	2002-03-28
CN1112926C (en)	2003-07-02
ZA984826B (en)	1999-08-03
DZ2510A1 (en)	2003-01-25
MXPA99011322A (en)	2004-12-02
IL133074A0 (en)	2001-03-19
EA002384B1 (en)	2002-04-25
ZA9811572B (en)	1999-07-22
AR015120A1 (en)	2001-04-18
SK164899A3 (en)	2000-11-07
CN1526391A (en)	2004-09-08
KR20010013410A (en)	2001-02-26
CN1259050A (en)	2000-07-05
CN1430959A (en)	2003-07-23
JP2001521553A (en)	2001-11-06
CA2333352A1 (en)	1998-12-10
UY25032A1 (en)	1998-11-26
HUP0004070A2 (en)	2002-02-28
TR200002790T2 (en)	2001-11-21
AR008198A1 (en)	1999-12-29
CA2292629A1 (en)	1998-12-10
NZ513922A (en)	2001-09-28
NO20040738L (en)	2000-02-02
GB9711683D0 (en)	1997-08-06
AP9901696A0 (en)	1999-12-31
ID24264A (en)	2000-07-13

Publication	Publication Date	Title
NO20024307D0 (en)	2002-09-09	Hydrochloride salts of 5- [4- [2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
NO2001005I2 (en)	2004-06-01	5-A4-A2- (N-methyl-N- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2,4-dione, maleic acid salt
FI933804A (en)	1994-03-02	Monohydrate 5- (2- (4- (1,2-benzisothiazol-3-yl) -1-piperazinyl) ethyl-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride
NO995938D0 (en)	1999-12-03	Mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
IL146111A0 (en)	2002-07-25	5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt
AP2000001831A0 (en)	2000-06-30	5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin e-2,4-dione maleic acid salt hydrate as pharmaceutical
IL155036A0 (en)	2003-10-31	Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] benzyl] thiazolidine-2,4-dione maleate and pharmaceutical compositions containing the same
AP2000001830A0 (en)	2000-06-30	Hydrate of 5-[4-[2-(n-methyl-n-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
DK0927173T3 (en)	2002-09-16	Substituted [2- (1-piperazinyl) ethoxy] methyl compounds
DK1315723T3 (en)	2005-10-24	The hydrochloride salt of 5 [4- [2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
AU2002343036A1 (en)	2003-06-10	5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2,4-dione and pharmaceutical compositions comprising the same
ATE525362T1 (en)	2011-10-15	2-(3-(4-(2-T-BUTYL-6-TRIFLUORMETHYLPYRIMIDINE-4-
IL188116A0 (en)	2008-03-20	Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
IL160144A0 (en)	2004-06-20	Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione
AU6255001A (en)	2001-12-17	5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
PT102339A (en)	1999-12-31	Hydrochloride salt of a substituted thiazolidinodione derivative
SI1265893T1 (en)	2005-12-31	Hydrochloride salts of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione

Legal Events

Date	Code	Title	Description
2005-10-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application